Using flow cytometry to evaluate the potential of targeting the "ERK1/2-STATS3-MCL-1 axis as a therapeutic strategy to overcome chemoresistance in acute myeloid leukaemia
|Short title||Flow cytometer for assessing the impact of a new therapaeutic strategy in Acute myeloid leukaemia|
|Effective start/end date||12/02/20 → 12/02/21|
- Tenovus Scotland: £20,000.00
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.